Related Experiment Videos
Prostaglandin binding sites in human polymorphonuclear neutrophils
1Dept. of Medicine, Wake Forest University Medical School, Winston-Salem, North Carolina 27103.
Prostaglandins
|June 1, 1989
Summary
Prostaglandin E2 and Prostaglandin D2 inhibit neutrophil degranulation by binding to specific receptors on the cell surface. These prostaglandins act as crucial stop signals, regulating inflammatory responses.
Area of Science:
- Immunology
- Biochemistry
- Cell Biology
Background:
- Neutrophil degranulation is a key inflammatory response.
- Leukotriene B4 and Platelet-Activating Factor are potent stimulators of neutrophil degranulation.
- Prostaglandins are known mediators of inflammation.
Purpose of the Study:
- To investigate the inhibitory effects of Prostaglandin E2 (PGE2) and Prostaglandin D2 (PGD2) on neutrophil degranulation.
- To characterize the binding of PGE2 and PGD2 to polymorphonuclear neutrophils (PMNs).
Main Methods:
- Inhibition assays measuring PMN degranulation in response to stimuli.
- Radioligand binding studies using [3H]PGE2 and [3H]PGD2 on intact PMNs and isolated plasma membranes.
- Competitive binding experiments to differentiate receptor sites.
Main Results:
- PGE2 and PGD2 significantly inhibited PMN degranulation induced by LTB4 and PAF.
- PGF2 alpha showed no inhibitory activity.
- [3H]PGE2 and [3H]PGD2 demonstrated specific, saturable, and reversible binding to PMNs.
- Distinct binding sites were identified for PGE2 (high and low affinity) and PGD2 on the PMN plasma membrane.
Conclusions:
- PGE2 and PGD2 bind to specific plasmalemmal receptors on PMNs.
- These prostaglandins attenuate PMN function, acting as endogenous stop signals.
- This mechanism helps regulate inflammatory processes by limiting excessive neutrophil activation.